Ouro Medicines Limited

Research activity is centred on seropositive autoimmune disease, with clinical interest in Sjögren’s disease and idiopathic inflammatory myopathy. The sponsor’s trial portfolio reflects a focus on conditions marked by immune-mediated tissue damage and persistent systemic inflammation.

• Sjögren’s disease
• Idiopathic inflammatory myopathy
• Seropositive autoimmune disease

These areas indicate therapeutic involvement in disorders affecting glandular function, muscle inflammation, and broader autoimmune pathology.